Remote Controlled CARs: Towards a Safer Therapy for Leukemia
- PMID: 27339039
- DOI: 10.1158/2326-6066.CIR-16-0132
Remote Controlled CARs: Towards a Safer Therapy for Leukemia
Abstract
Genetic engineering of patient T cells with chimeric antigen receptors (CAR T cells) provides a powerful tool for inducing remissions in patients with various cancers derived from B cells. Challenges stemming from the inability to control the CAR T cells once given pose significant safety concerns. An article in Cancer Immunology Research presents an approach to circumvent this issue. Cancer Immunol Res; 4(8); 643. ©2016 AACRSee article by Sakemura et al., p. 658.
©2016 American Association for Cancer Research.
Comment on
-
A Tet-On Inducible System for Controlling CD19-Chimeric Antigen Receptor Expression upon Drug Administration.Cancer Immunol Res. 2016 Aug;4(8):658-68. doi: 10.1158/2326-6066.CIR-16-0043. Epub 2016 Jun 21. Cancer Immunol Res. 2016. PMID: 27329987
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical